Structural heart disease is the fastest growing subspeciality in cardiology. Interventional success is highly dependant on pre- and periprocedural imaging. The working group is concentrating on the evaluation of the clinical benefit through these novel modalities. Coagulation Managmenet in structural heart interventions is the second focus. We assess platelet function and drug drug interaction.